newsfilter
← Latest News
GlobeNewswire·

Barrack, Rodos & Bacine Investigates GeneDx Holdings Corp. (NASDAQ: WGS) For Possible Securities Fraud

  • Barrack, Rodos & Bacine is investigating GeneDx Holdings Corp. (NASDAQ: WGS) on behalf of shareholders who lost money.
  • GeneDx reported a Q1 2026 operational loss of $57.5 million and an EPS of -$0.28.
  • The company lowered its full-year guidance by approximately $65 million at the midpoint.
  • A $31.3 million write-down was recorded for goodwill and intangible assets related to the fabric genomics unit.
  • GeneDx shares fell over 49% ($33.42 per share) following the May 4, 2026, announcement.
  • Injured investors are encouraged to contact Linda Border or Mark Stein at 877-386-3304 or via email at investoralert@barrack.com.
  • Barrack, Rodos & Bacine has over 40 years of experience in securities class actions with major recoveries including $6.19 billion for WorldCom investors.